Newsroom

NEW YORK--(BUSINESS WIRE)--Ares Capital Corporation (“Ares Capital” or the “Company”) (NASDAQ: ARCC) announced today the tax treatment of the Company’s 2025 common stock distributions (CUSIP #: 04010L103).       Ordinary Income Per Share     Record Date Payable Date Total Paid Per Share Ordinary Rate 20% Rate (1) Long Term Capital Gains per Share (2) Interest - Related Dividends (3) 3/14/2025 3/31/2025 $ 0.4800 $ 0.339128 $ 0.140872 $ 0.0000 84.7500% 6/13/2025 6/30/2025 $ 0.4800 $ 0.339128 $ 0....

MORGES, Schweiz--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) hat heute bekannt gegeben, dass das Committee for Medicinal Products for Human Use (CHMP) der Europäischen Arzneimittelagentur (European Medicines Agency, EMA) eine positive Stellungnahme abgegeben hat, in der die Zulassung von Zynyz® (Retifanlimab) in Kombination mit Carboplatin und Paclitaxel (platinbasierte Chemotherapie) zur Erstlinienbehandlung von erwachsenen Patienten mit metastasiertem oder inoperablem lokal rezidivierendem Platten...

MORGES, Svizzera--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato che il Comitato per i medicinali per uso umano (CHMP) dell'Agenzia europea per i medicinali (EMA) ha rilasciato il parere favorevole che ha raccomandato l'approvazione di Zynyz® (retifanlimab) in combinazione con carboplatino e paclitaxel (chemioterapia a base di platino) per il trattamento di prima linea di pazienti adulti con carcinoma anale squamocellulare (SCAC) localmente ricorrente metastatico o inoperabile. Il tes...

MIAMI--(BUSINESS WIRE)--Ocean Bank today announced double-digit growth in assets, deposits and stockholder’s equity for 2025, compared to year-end 2024. Total assets reached $7.44 billion, an increase of 11 percent during the year, while deposits grew 12 percent to $6.27 billion. “This growth reflects Ocean Bank’s constant dedication to meeting our customers’ needs,” said Agostinho Alfonso Macedo, President, Chairman and CEO of Ocean Bank. “Strong customer relationships drove increases in loans...

MORGES, Suisse--(BUSINESS WIRE)--Incyte (Nasdaq : INCY) a annoncé aujourd'hui que le Comité des médicaments à usage humain (CHMP) de l'Agence européenne des médicaments (EMA) a émis un avis positif recommandant l'approbation de Zynyz® (retifanlimab) en association avec le carboplatine et le paclitaxel (chimiothérapie à base de platine) pour le traitement de première ligne des patients adultes atteints d'un carcinome épidermoïde métastatique ou localement récidivant inopérable du canal anal (SCA...

PARIS et LOS ANGELES--(BUSINESS WIRE)--Mediawan, le studio indépendant européen de premier plan dirigé par Pierre-Antoine Capton, et cofondé par ce dernier, Xavier Niel et Matthieu Pigasse, a annoncé aujourd’hui la signature d’un accord en vue d’acquérir The North Road Company (« North Road »), le studio indépendant américain majeur fondé par Peter Chernin. Cette union donne naissance à l’un des plus grands studios indépendants au monde, avec des pôles créatifs majeurs sur les cinq continents e...

MORGES (Suiza)--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) anunció hoy que el Comité de Medicamentos de Uso Humano (CMUH) de la Agencia Europea de Medicamentos (EMA) emitió una opinión positiva en la que recomienda la aprobación de Zynyz® (retifanlimab) en combinación con carboplatino y paclitaxel (quimioterapia basada en platino) para el tratamiento de primera línea de pacientes adultos con carcinoma de células escamosas del canal anal recurrente metastásico o inoperable localmente. El comunicado...

ANAHEIM, Calif.--(BUSINESS WIRE)--Willdan Group, Inc. (“Willdan”) (Nasdaq: WLDN), today announced that it will release its financial results for the fourth quarter 2025 after the close of the stock market on Thursday, February 26, 2026. Following the release, Willdan will host its investor conference call at 5:30 p.m. ET / 2:30 p.m. PT. An online, real-time audio webcast of the quarterly investor conference call will be available on Willdan’s website at: Willdan Group Q4 2025 Investor Conferenc...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6, 2024 and November 10, 2025. Bitdeer is a bitcoin mining and high-performance computing (HPC) data-center infrastructure company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigati...

PARÍS y LOS ÁNGELES--(BUSINESS WIRE)--Mediawan, el estudio europeo líder del sector, dirigido por Pierre-Antoine Capton y cofundado por Pierre-Antoine Capton, Xavier Niel y Matthieu Pigasse, anunció hoy la firma de un acuerdo para adquirir The North Road Company («North Road»), el estudio estadounidense de referencia fundado por Peter Chernin. La operación dará lugar a uno de los mayores estudios del mundo, con importantes centros creativos en los cinco continentes y presencia en todos los géne...